Author:
Klingenberg R.-E., ,Esser S.,Brockmeyer N. H.,Michalik C.,Skaletz-Rorowski A.,Potthoff A.
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Hoffmann C, Esser S (2014) Kaposi-Sarkom. In: Hoffmann C, Rockstroh JK (Hrsg) HIV 2014/15. Medizin Fokus Verlag, Hamburg, S 426–433
2. Vogt T, Brockmeyer N, Kutzner H, Schöfer H (2013) S1 Kurzleitlinie – Angiosarkom der Haut und Kaposi-Sarkom. J Dtsch Dermatol Ges 11:2–10
3. Jansen K, Michalik C, Hahn M, Dupke S, Esser S, Jaeger H, Köppe S, Moll A, Plettenberg A, Schmidt RE, Skaletz-Rorowski A, Brockmeyer NH, Competence Network for HIV/AIDS (2009) The patient cohort of the German competence network for HIV/AIDS (Kompnet): a profile. Eur J Med Res 14(8):323–331
4. Kreuter A, Rasokat H, Klouche M, Esser S, Bader A, Gambichler T, Altmeyer P, Brockmeyer NH (2005) Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi’s sarcoma; retrospective analysis of three German centers. Cancer Invest 23(8):653–659
5. Hengge UR, Esser S, Rudel HP, Goos M (2001) Long-term chemotherapy of HIV-associated Kaposi’s sarcoma with liposomal doxorubicin. Eur J Cancer 37(7):878–883
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献